OCALIVA (obeticholic acid) Intercept pharms inc Patent: 7,138,390 Expiration: Nov 16, 2022 See More … For more information on how […]
Drug Patent Expirations for the Week of November 13, 2022 Read Post »
Annual Drug Patent Expirations for HORIZANT Horizant is a drug marketed by Azurity and is included in one NDA. It
Annual Drug Patent Expirations for CHANTIX Chantix is a drug marketed by Pf Prism Cv and is included in one
OSPHENA (ospemifene) Duchesnay Patent: 9,566,252 Expiration: Nov 2, 2022 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of October 30, 2022 Read Post »
Annual Drug Patent Expirations for OSPHENA Osphena is a drug marketed by Duchesnay and is included in one NDA. It
New patent expiration for Duchesnay drug OSPHENA Read Post »
Annual Drug Patent Expirations for RYDAPT Rydapt is a drug marketed by Novartis and is included in one NDA. It
TRI-LUMA (fluocinolone acetonide; hydroquinone; tretinoin) Galderma labs lp Patent: 8,653,053 Expiration: Oct 25, 2022 See More … For more information
Drug Patent Expirations for the Week of October 23, 2022 Read Post »
Annual Drug Patent Expirations for TRI-LUMA Tri-luma is a drug marketed by Galderma Labs Lp and is included in one
New patent expiration for Galderma Labs drug TRI-LUMA Read Post »
Annual Drug Patent Expirations for GRALISE Gralise is a drug marketed by Almatica and is included in one NDA. It
Get fresh news and insights, drug patent expirations & more…
